No Matches Found
No Matches Found
No Matches Found
Granules India Ltd
Granules India Ltd is Rated Buy
Granules India Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Granules India Ltd is Rated Buy by MarketsMOJO
Granules India Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with the most recent and relevant data to assess the company’s prospects.
Granules India Gains 2.75%: 5 Key Factors Driving the Week’s Rally
Granules India Ltd delivered a solid weekly gain of 2.75%, outperforming the Sensex which remained virtually flat with a 0.01% rise. The stock demonstrated strong momentum, hitting multiple 52-week and all-time highs during the week, supported by robust financial results, institutional buying, and bullish technical indicators. Despite a mixed market backdrop, Granules India’s resilience in the Pharmaceuticals & Biotechnology sector was evident through its price appreciation and active trading volumes.
Broad-Based Technical Strength Lifts Granules India Ltd to 52-Week High of Rs 804.05
With a decisive surge to Rs 804.05 on 29 May 2026, Granules India Ltd has reached a new 52-week and all-time high, marking a 47.5% rally from its low of Rs 433 over the past year. This milestone reflects a powerful alignment of technical indicators and sustained price momentum that has propelled the stock well ahead of the broader market.
Granules India Ltd Hits All-Time High of Rs 804.05 as Momentum Builds Across Timeframes
Extending its recent rally, Granules India Ltd touched a fresh all-time high of Rs 804.05 on 29 May 2026, outperforming its sector and the broader market with a 1.95% gain on the day.
Granules India Ltd Surges to New High on Robust Trading Activity and Institutional Interest
Granules India Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in trading activity on 27 May 2026, driven by robust value turnover and heightened institutional interest. The stock hit a new 52-week and all-time high of Rs 785, outperforming its sector peers and signalling renewed investor confidence amid a backdrop of strong technical and fundamental indicators.
Broad-Based Technical Strength Lifts Granules India Ltd to 52-Week High of Rs 793.35
Surging past its previous peaks, Granules India Ltd touched a new 52-week high of Rs 793.35 on 27 May 2026, marking a remarkable 50.9% gain over the past year. This milestone underscores the stock’s robust price momentum, supported by a confluence of bullish technical indicators across multiple timeframes.
Broad-Based Technical Strength Lifts Granules India Ltd to 52-Week High of Rs 793.35
Surging past its previous peaks, Granules India Ltd touched a fresh 52-week high of Rs 793.35 on 27 May 2026, marking a remarkable 51.4% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the broader Sensex trades slightly lower, underscoring the stock's relative strength.
Granules India Ltd Hits All-Time High of Rs 785 as Momentum Builds Across Timeframes
Extending its impressive rally, Granules India Ltd surged to a fresh all-time high of Rs 785 on 27 May 2026, outpacing the broader market and its sector with a 3.62% gain on the day against a flat Sensex. This milestone caps a remarkable run that has seen the stock outperform the benchmark indices by a wide margin over multiple timeframes.
Broad-Based Technical Strength Lifts Granules India Ltd to 52-Week High of Rs 777.65
With a decisive surge to Rs 777.65 on 26 May 2026, Granules India Ltd has reached a fresh 52-week and all-time high, propelled by a confluence of robust technical indicators and sustained price momentum.
Granules India Ltd Hits All-Time High of Rs 775.60 as Momentum Builds Across Timeframes
Extending its recent gains, Granules India Ltd surged 2.30% on 26 May 2026 to close at Rs 775.60, just 0.36% above its previous 52-week high of Rs 772.85. This fresh peak caps a remarkable run that has seen the stock outperform the Sensex by a wide margin over multiple timeframes, signalling strong investor interest and robust underlying momentum.
Granules India Gains 2.34%: 2 Key Factors Driving the Weekly Momentum
Granules India Ltd recorded a moderate weekly gain of 2.34% from Rs.734.45 to Rs.751.60 between 18 and 22 May 2026, outperforming the Sensex which rose 0.50% over the same period. The stock’s performance was marked by a significant surge on 19 May, when it hit both a new 52-week high and an all-time high, supported by robust financial results and strong technical indicators. Despite some volatility later in the week, Granules India maintained its positive momentum within the Pharmaceuticals & Biotechnology sector.
Granules India Ltd is Rated Buy by MarketsMOJO
Granules India Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.
Broad-Based Technical Strength Lifts Granules India Ltd to 52-Week High of Rs 763
Surging to a fresh 52-week high of Rs 763 on 19 May 2026, Granules India Ltd has demonstrated remarkable price momentum, outperforming its sector by 3.25% in a single session. This milestone caps a year-long rally that has seen the stock appreciate 49.00%, significantly outpacing the Sensex’s decline of 8.04% over the same period.
Granules India Ltd Hits All-Time High of Rs 761 as Momentum Builds Across Timeframes
Extending its winning streak after a brief pause, Granules India Ltd surged 4.15% on 19 May 2026 to close at a fresh all-time high of Rs 761, outpacing the Sensex which rose a modest 0.27% on the day. This milestone caps a remarkable run that has seen the stock appreciate nearly 49% over the past year, significantly outperforming the broader market.
Granules India Ltd is Rated Buy
Granules India Ltd is rated Buy by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 May 2026, providing investors with the latest insights into the company’s fundamentals, returns, and market performance.
Granules India Ltd Gains 6.94%: 4 Key Factors Driving the Week’s Rally
Granules India Ltd delivered a strong weekly performance, rising 6.94% from Rs.703.55 on 4 May to Rs.752.40 on 8 May 2026, significantly outperforming the Sensex’s 1.25% gain over the same period. The stock’s rally was marked by multiple new 52-week and all-time highs, supported by robust financial results, increased institutional interest, and positive technical indicators, despite some volatility in the broader market.
Broad-Based Technical Strength Lifts Granules India Ltd to 52-Week High of Rs 756
With a decisive break above Rs 750, Granules India Ltd has surged to a fresh 52-week high of Rs 756 on 8 May 2026, marking a remarkable 72.25% gain over the past year. This rally is underpinned by a strong alignment of technical indicators and sustained price momentum, even as the broader Sensex trades lower by 0.41%.
Granules India Ltd Hits All-Time High of Rs 755.85 as Momentum Builds Across Timeframes
Granules India Ltd has reached a significant milestone by touching its all-time high price of ₹755.85 on 08 May 2026, reflecting a sustained period of robust performance and investor confidence in the pharmaceuticals and biotechnology sector.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
